Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

DNA Damage Can Stall the Cell Cycle

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ultrafine particulate matter emitted from ships drives inflammation and susceptibility to viral infection.

Environment international·2026

Same author

Phosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine.

PloS one·2026

Same author

Cytotoxic Effects of a Triorganotin Derivative on HTLV-1-Infected Cells at Different Immortalization/Transformation Stages In Vitro.

Molecules (Basel, Switzerland)·2026

Same author

Unraveling the Potential Antiviral Activity of Isoxazoline-Carbocyclic Monophosphate Nucleotides Against Echovirus 11.

Microorganisms·2025

Same author

Discovery of Influenza Neuraminidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation of Novel Chemotypes.

Molecules (Basel, Switzerland)·2025

Same author

Structure-Function Insights into Frog Skin Peptides Reveal Potent Inhibition of West Nile Virus Entry.

International journal of molecular sciences·2025

Search research articles

Related Experiment Video

Updated: May 30, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

p73 in Cancer.

Alessandro Rufini¹, Massimiliano Agostini, Francesca Grespi

¹Toxicology Unit, Medical Research Council, Leicester, LE1 9HN, United Kingdom.

|July 23, 2011

Summary

This summary is machine-generated.

The balance between p73 isoforms, TAp73 and ΔNp73, is critical in cancer. TAp73 acts as a tumor suppressor, while ΔNp73 has oncogenic properties, influencing tumor progression and therapy response.

Keywords:

knockout mice mitosis mutant p53 neuroblastoma p73 rhabdomyosarcoma

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Experiment Videos

Last Updated: May 30, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Area of Science:

Molecular Biology
Oncology
Genetics

Background:

p73, a p53 family member, exists as distinct isoforms (TAp73 and ΔNp73) due to alternative promoter use and splicing.
TAp73 functions as a tumor suppressor, inducing cell death and cell cycle arrest.
ΔNp73 exhibits oncogenic properties, inhibiting TAp73 and p53, and can act in a dominant-negative manner.

Purpose of the Study:

To review recent findings on the role of p73 isoforms in cancer development and progression.
To highlight the significance of the TAp73/ΔNp73 ratio in tumorigenesis and therapeutic strategies.
To discuss the implications of p73 dysfunction in human cancers, particularly neuroblastoma.

Main Methods:

Utilized isoform-specific knockout mice to differentiate the roles of TAp73 and ΔNp73 in tumorigenesis.
Analyzed transcriptional and posttranslational regulation of p73 isoform activity.
Examined p73 isoform expression and function in human cancer models, including neuroblastoma.

Main Results:

p73 dysfunction, especially TAp73 loss, is linked to mitotic abnormalities, polyploidy, and aneuploidy, contributing to cancer.
Mutant p53 can inhibit the tumor-suppressive activity of TAp73, impacting therapeutic outcomes.
The ratio of TAp73 to ΔNp73 is a key determinant of tumor progression and response to cancer therapy.

Conclusions:

The functional balance between TAp73 and ΔNp73 is crucial for maintaining cellular homeostasis and preventing cancer.
Targeting the p73 pathway, considering the isoform balance, holds potential for novel cancer therapies.
Understanding p73 isoform dynamics is essential for predicting patient prognosis and optimizing treatment strategies in various human cancers.